Latest debt-to-equity ratio
Xilio Therapeutics Debt-to-equity ratio
Direct answer
Xilio Therapeutics's debt-to-equity ratio is 8.72%.
The verified market snapshot reports 8.72%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Xilio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 8.72%
Explore related company data
View Xilio Therapeutics's market capitalizationView Xilio Therapeutics's price-to-book ratioView Xilio Therapeutics's return on equityView Xilio Therapeutics's dividend yieldView Xilio Therapeutics's 52-week price rangeView Xilio Therapeutics's revenue growthView Xilio Therapeutics's profit marginView all Xilio Therapeutics key metricsReturn to Xilio Therapeutics profile